Gilead Sciences Inc (NASDAQ:GILD)

101.38
Delayed Data
As of Apr 17
 -1.96 / -1.90%
Today’s Change
69.09
Today|||52-Week Range
116.83
+7.55%
Year-to-Date

Today’s Trading

Previous close103.34
Today’s open102.35
Day’s range100.61 - 102.81
Volume9,896,452
Average volume (3 months)11,909,277
Market cap$150.4B
Dividend yield--
Data as of 4:14pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+306.08%
Earnings growth (this year)+18.60%
Earnings growth (next 5 years)+8.65%
Revenue growth (last year)+121.81%
P/E ratio13.8
Price/Sales5.76
Price/Book9.85

Competitors

 Today’s
change
Today’s
% change
AMGNAmgen-3.29-1.97%
BIIBBiogen-9.21-2.15%
BAXBaxter International...-0.24-0.34%
JUNOJuno Therapeutics In...+0.16+0.25%
Data as of 4:14pm ET, 04/17/2015

Financials

Next reporting dateApril 21, 2015
EPS forecast (this quarter)$2.29
Annual revenue (last year)$24.9B
Annual profit (last year)$12.1B
Net profit margin48.62%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
John C. Martin
President &
Chief Operating Officer
John F. Milligan
Corporate headquarters
Foster City, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers